Literature DB >> 28442529

Coinheritance of Novel Mutations in SCN1A Causing GEFS+ and in KDM6A Causing Kabuki Syndrome in a Family.

Jisun Kim1, Cha Gon Lee2.   

Abstract

Because the differentiation between phenotypic expansion and blended phenotypes is not clear, the mixed phenotypes of blended rare genetic diseases make diagnosis difficult. We describe a family with the co-existence and co-segregation of generalized epilepsy with febrile seizures plus (GEFS+) and Kabuki syndrome (KS). The proband, a 7-year-old male, presented with GEFS+, dysmorphic facial features, short stature, developmental delay, and intellectual disability. Two novel missense mutations: p.G325A in the KDM6A gene responsible for KS and p.G1877V in the SCN1A gene responsible for GEFS+ were identified using the TruSight One sequencing panel. This family is the first in the literature to be confirmed molecularly with the blended phenotype of GEFS+ and KS. Furthermore, two affected female patients with X-linked KS showed a partial escape X-inactivation pattern of KDM6A with milder phenotypes than the male affected proband in this study.
© 2017 by the Association of Clinical Scientists, Inc.

Entities:  

Keywords:  Dravet syndrome; KDM6A gene; Kabuki syndrome; SCN1A gene; generalized epilepsy with febrile seizures plus (GEFS+)

Mesh:

Substances:

Year:  2017        PMID: 28442529

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  6 in total

1.  Cancer-derived UTX TPR mutations G137V and D336G impair interaction with MLL3/4 complexes and affect UTX subcellular localization.

Authors:  Hiroyuki Kato; Kaori Asamitsu; Wendi Sun; Shojiro Kitajima; Naoko Yoshizawa-Sugata; Takashi Okamoto; Hisao Masai; Lorenz Poellinger
Journal:  Oncogene       Date:  2020-02-18       Impact factor: 9.867

2.  Case Report: Phenotype-Driven Diagnosis of Atypical Dravet-Like Syndrome Caused by a Novel Splicing Variant in the SCN2A Gene.

Authors:  Artem Sharkov; Peter Sparber; Anna Stepanova; Denis Pyankov; Sergei Korostelev; Mikhail Skoblov
Journal:  Front Genet       Date:  2022-05-31       Impact factor: 4.772

Review 3.  Kabuki syndrome: review of the clinical features, diagnosis and epigenetic mechanisms.

Authors:  Yi-Rou Wang; Nai-Xin Xu; Jian Wang; Xiu-Min Wang
Journal:  World J Pediatr       Date:  2019-10-05       Impact factor: 2.764

4.  The KMT2D Kabuki syndrome histone methylase controls neural crest cell differentiation and facial morphology.

Authors:  Karl B Shpargel; Cassidy L Mangini; Guojia Xie; Kai Ge; Terry Magnuson
Journal:  Development       Date:  2020-07-17       Impact factor: 6.862

5.  UTX Affects Neural Stem Cell Proliferation and Differentiation through PTEN Signaling.

Authors:  Xuepei Lei; Jianwei Jiao
Journal:  Stem Cell Reports       Date:  2018-03-15       Impact factor: 7.765

6.  Inhibition of Notch signaling rescues cardiovascular development in Kabuki Syndrome.

Authors:  Maria de Los Angeles Serrano; Bradley L Demarest; Tarlynn Tone-Pah-Hote; Martin Tristani-Firouzi; H Joseph Yost
Journal:  PLoS Biol       Date:  2019-09-03       Impact factor: 8.029

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.